Genomic Health: New Real-World Clinical Practice Data
26.03.2018
Share this article
Genomic Health today announced the presentation of new data with the Oncotype DX® test at the 11th European Breast Cancer Conference (EBCC-11) in Barcelona, Spain
The presentations underline the substantial real-world evidence available for Oncotype DX and reflect the growing adoption of the test across Europe to personalize and improve the quality of clinical decisions, leading to better patient outcomes and more cost-effective treatment.